Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Melanie L. Grant"'
Autor:
Carl G. Simon, Erich H. Bozenhardt, Christina M. Celluzzi, David Dobnik, Melanie L. Grant, Uma Lakshmipathy, Thiana Nebel, Linda Peltier, Anthony Ratcliffe, James L. Sherley, Glyn N. Stacey, Rouzbeh R. Taghizadeh, Eddie H. P. Tan, Sandrine Vessillier
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-17 (2024)
Abstract One of the most challenging aspects of developing advanced cell therapy products (CTPs) is defining the mechanism of action (MOA), potency and efficacy of the product. This perspective examines these concepts and presents helpful ways to thi
Externí odkaz:
https://doaj.org/article/1a4c1b7ac9dd4b808e25bb9e5b77ce01
Autor:
Katherine M. Harris, Sarah E. Horn, Melanie L. Grant, Haili Lang, Gelina Sani, Mariah A. Jensen-Wachspress, Vaishnavi V. Kankate, Anushree Datar, Christopher A. Lazarski, Catherine M. Bollard, Michael D. Keller
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Human Parainfluenza Virus-3 (HPIV3) causes severe respiratory illness in immunocompromised patients and lacks approved anti-viral therapies. A phase I study of adoptively transferred virus-specific T-cells (VSTs) targeting HPIV3 following bone marrow
Externí odkaz:
https://doaj.org/article/1c0c8c5a128044ef956b7b90341eadb6
Autor:
Nataly Shtraizent, Scott E. Plevy, Jeffrey P. Krischer, Michael Jerrett, Emeran A. Mayer, Andrés Hurtado-Lorenzo, Joshua R. Korzenik, Stephen M. Rappaport, Manolis Kellis, Gary D. Wu, James D. Lewis, Melanie L Grant, Charles N. Bernstein, Emil Chuang, Kenneth Croitoru, Gerard Honig, Jeffrey S. Hyams, Richard S. Judson, Gary W. Miller, Shuk-Mei Ho
Publikováno v:
Inflammatory Bowel Diseases. 25:S13-S23
Environmental triggers is part of five focus areas of the Challenges in IBD research document, which also includes preclinical human IBD mechanisms, novel technologies, precision medicine and pragmatic clinical research. The Challenges in IBD researc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5453c10322afeb90e46be787c940794
https://doi.org/10.1093/ibd/izz076
https://doi.org/10.1093/ibd/izz076
Autor:
Sarah L. Young, Christopher Jackson, Silke Neumann, Andrea Bonato, Nicholas J. Shields, Katrin Kramer, Margaret A. Baird, Melanie L Grant
Publikováno v:
Clinical & Translational Immunology
The dendritic cell (DC) is the foremost antigen-presenting cell (APC) for ex vivo expansion of tumour-specific patient T cells. Despite marked responses in some patients following reinfusion of DC-activated autologous or HLA-matched donor T cells, ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4380e86312f209427d1d56370606826
http://europepmc.org/articles/PMC5539416
http://europepmc.org/articles/PMC5539416